Key Trends Influencing the Growth of the Drug Discovery Outsourcing Market in 2025: Innovation Surge In Drug Discovery Outsourcing With Launch Of New Digital Health Solutions

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Drug Discovery Outsourcing Market Through 2025?
There has been a significant growth in the market size of drug discovery outsourcing in the past few years. The market is projected to expand from $3.92 billion in 2024 to $4.24 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the historical period include the increasing complexity of drug discovery, the necessity for specialized knowledge, strict regulatory standards, the internationalization of clinical trials, and a surge in demand for orphan drugs and personalized treatments.

What's the Projected Size of the Global Drug Discovery Outsourcing Market by 2029?
Expect a significant surge in the drug discovery outsourcing market in the upcoming years, with its value anticipated to hit $5.72 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.8%. The predicted growth during this forecast period is backed by factors such as growing expenditure on research and development, imminent patent expirations, expansion within the biopharmaceutical sector, a concentration on core competencies, and the urgency to minimize time-to-market. Future trends likely to dominate this period consist of the integration of artificial intelligence, technological progression, the use of big data analytics, specialty drugs, along with collaboration and strategic alliances.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-outsourcing-global-market-report

Top Growth Drivers in the Drug Discovery Outsourcing Industry: What's Accelerating the Market?
The surge in chronic diseases is anticipated to catalyze the expansion of the drug discovery outsourcing market. These are health conditions that persist for prolonged periods, potentially lifelong, and are escalating due to a variety of factors including an aged population, lifestyle habits, urbanization, and environmental aspects. Outsourcing drug discovery bolsters the creation of chronic disease treatments by providing specialized expertise and high-tech solutions, thus reducing durations and expenditures. In June 2024, it was reported by the Australian Institute of Health and Welfare, a government organization in Australia, that of the population, 61% or around 15.4 million people had a long-term health condition, leading to 90% of deaths in 2022. Anxiety impacted 1.3 million (16%) individuals from 0-24 years and 1.6 million (22%) from the age group 25-44. Back issues affected 1.5 million (23%) individuals in the 45-64 age bracket, while deafness or hearing loss was experienced by 1.3 million (32%) individuals aged 65 and above. Consequently, the rising prevalence of chronic diseases propels the drug discovery outsourcing market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19405&type=smp

What Trends Will Shape the Drug Discovery Outsourcing Market Through 2029 and Beyond?
Key players in the drug discovery outsourcing market are striving to develop innovative strategies, like digital health solutions, to better cater to the needs of healthcare practitioners, regulatory bodies, and patients. Digital health solutions involve the use of technologies and services, such as telemedicine, health apps on mobile devices, and wearable gadgets, which improve the provision of healthcare, patient involvement, and health management. For instance, Evinova, an advanced health-tech venture was established by AstraZeneca PLC, a UK-based biopharmaceutical entity, in November 2023. This initiative is geared towards promoting innovation in the life sciences sector and enhancing the execution of clinical trials. With an emphasis on improving health results, it aspires to offer digital products and services on a global scale that have demonstrated their efficiency in AstraZeneca's clinical trials conducted in over 40 countries. Through the optimization of clinical trial planning and execution, Evinova aims to simplify the process of developing new drugs, ultimately leading to time and cost efficiency.

What Are the Main Segments in the Drug Discovery Outsourcing Market?
The drug discovery outsourcingmarket covered in this report is segmented -

1) By Service Type: Chemistry Services, Biological Services
2) By Workflow: Target Identification And Screening, Target Validation And Functional Informatics, Lead Identification And Candidate Optimization, Preclinical Development, Other Workflows
3) By Disease Model: In Vitro Models, Animal Models, Cellular Models, Other Disease Models
4) By Therapeutic Area: Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Other Therapeutic Areas
5) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:
1) By Chemistry Services: Custom Synthesis And Manufacturing, Medicinal Chemistry, Combinatorial Chemistry, Hit Identification And Lead Optimization, Process Chemistry And Scale-Up, Analytical Chemistry Services, Chemical Library Design And Screening, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
2) By Biological Services: Cell-Based Assays And Screening, Target Identification And Validation, In Vitro And In Vivo Testing, Biomarker Discovery And Development, Toxicology Studies, Genomics And Proteomics Services, Animal Models For Preclinical Development, Biological Safety And Efficacy Testing, Biopharmaceutical Development And Manufacturing.

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19405&type=smp

Which Top Companies are Driving Growth in the Drug Discovery Outsourcing Market?
Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited

Which Regions Will Dominate the Drug Discovery Outsourcing Market Through 2029?
North America was the largest region in the drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19405

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.